In acute myeloid leukemia (AML), disease relapse is often observed because of therapy-resistant leukemic stem cells that re-initiate the disease. Leukemic stem cells can tightly associate with mesenchymal stromal cells inside the bone marrow, which is considered to further drive drug resistance. Here, the cell membrane of bone marrow stromal cells is used to prepare cell membrane nanoparticles and study their interactions with AML cells. Cell membrane liposomes (CM-Liposomes) of different charge are prepared and either used directly, or after deposition on silica cores to modulate nanoparticle mechanical properties. Nanoparticle size, zeta potential and coating efficiency are analyzed by dynamic light scattering (DLS) and cryo electron microscopy (Cryo-EM) imaging. Atomic force microscopy (AFM) is used to characterize the mechanical properties of CM-Liposomes and confirm bilayer deposition on silica cores. Finally, uptake by leukemic cells is determined. No difference in uptake is found between soft CM-Liposomes and liposomes of the same composition without membrane components. Instead, after deposition on a rigid core, uptake is higher for the cell membrane particles. Preliminary results on primary cells from leukemia patients confirm this observation. These results show that nanoparticle rigidity strongly affects the interaction between cell membrane nanoparticles and the targeted cells.
Effect of Nanoparticle Rigidity on the Interaction of Stromal Membrane Particles with Leukemia Cells
纳米颗粒刚性对基质膜颗粒与白血病细胞相互作用的影响
阅读:5
作者:Sander de Weerd ,Xinyu Ma ,Zahra Zohali ,Lieve L Oudejans ,Emmanouil Kyrloglou ,Marc C A Stuart ,Wouter H Roos ,Jan Jacob Schuringa ,Anna Salvati
| 期刊: | Advanced Healthcare Materials | 影响因子: | 10.000 |
| 时间: | 2025 | 起止号: | 2025 Jul;14(19):e2500667. |
| doi: | 10.1002/adhm.202500667 | 研究方向: | 细胞生物学 |
| 疾病类型: | 白血病 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
